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Previewsmealybugs are representative of symbio-
sis-associated genome evolution in other
animal and plant systems. While nutri-
tional symbioses are ubiquitous across
insects, other intimate host-microbe
associations could undergo similar pro-
cesses of complex genome evolution
and integration.
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In this issue of Cell Host & Microbe, Deriu et al. present a mechanistic explanation underlying the benefits of
certain probiotic bacteria. Intestinal bacteria compete for the essential nutrient iron, leading to replacement
of pathogenic Salmonella by the probiotic Escherichia coli Nissle, which is better equipped with iron acqui-
sition systems, and resolution of infectious colitis.Iron homeostasis plays a decisive role
in host-pathogen interactions and the
course of infection (Cassat and Skaar,
2013; Nairz et al., 2010). This is, on the
one hand, due to the fact that iron is an
essential nutrient for microbes, whereas
this metal also exerts subtle effects on
host immune function. Specifically, iron
is central for several metabolic processes
in eukaryotic and prokaryotic cells and,
thus, is essential for the growth of micro-
organisms, including bacteria, viruses,
parasites, etc. (Cassat and Skaar, 2013;
Nairz et al., 2010). To ensure a satisfac-
tory supply of iron, microorganisms have
evolved different strategies for acquiring
this metal, which is available in their
environments in different forms. Such
acquisition strategies include iron uptake
by specific metal transporters and sidero-
phores, the latter of which are produced
and released by certain bacteria or fungi
in order to scavenge extracellular iron
and redeliver the metal to the microbe.Accordingly, the expression of such iron
uptake systems by microbes has been
linked to their pathogenicity (Andrews-
Polymenis et al., 2010).
On the other hand, iron exerts subtle
effects on immune function by affecting
the proliferation and differentiation of
immune cells, and, in addition, iron avail-
ability both positively and negatively regu-
lates host immune responses (Nairz et al.,
2013; Nairz et al., 2010). This latter Janus-
faced role of iron is due to the ability of this
metal to promote the formation of antimi-
crobial reactive oxygen species within
phagocytes and neutrophils but also
inhibit proinflammatory and interferon-g
(IFN-g)-driven immune responses by
macrophages (Fritsche et al., 2012; Nairz
et al., 2010). Furthermore, the importance
of iron in host responses to infection is
highlighted by the observation that
several innate phagocyte-resistance
genes, notably natural-resistance-associ-
ated macrophage protein 1 (NRAMP-1),lipocalin 2, and nitric oxide (NO), exert
their antimicrobial activity by limiting the
availability of iron to microbes. The ability
of these proteins to modulate cellular iron
homeostasis is partially interconnected
(Fritsche et al., 2012). NRAMP-1 is a
phagolysosomal protein that confers
resistance to infection with intracellular
pathogens by modifying metal and
hydrogen fluxes across the phagolysoso-
mal membrane and reducing intracellular
iron content, thereby promoting antimi-
crobial host immune responses (Cellier
et al., 2007). Lipocalin 2 is a small peptide
that binds certain iron-laden bacterial
siderophores, such as enterobactin, thus
inhibiting this iron scavenging system
and limiting the growth of several Gram-
negative bacteria (Chakraborty et al.,
2012). Finally, NO has recently been
shown to exert antimicrobial effects by
inducing the expression of the cellular
iron exporter ferroportin, which pumps
iron out of the cell, in macrophages. Thisbe 14, July 17, 2013 ª2013 Elsevier Inc. 3
Cell Host & Microbe
Previewscellular egress of iron not only limits the
availability of this metal for various patho-
genic bacteria, such as the intracellular
intestinal bacteria Salmonella, but also
stimulates antimicrobial macrophage
effector pathways (Nairz et al., 2013).
Thus, iron homeostasis is a central battle-
field that can determine the outcome of
an infection, and, accordingly, infection
and inflammation result in subtle alter-
ations in cellular and body iron
homeostasis.
In this issue of Cell Host & Microbe,
Deriu et al. (2013) add to our understand-
ing of how iron regulates infection and
provide a mechanistic explanation for
the beneficial effects of probiotic bacteria
in intestinal infectious and inflammatory
diseases. Using a mouse model of Sal-
monella Typhimurium-induced colitis,
Deriu et al. (2013) show that infection re-
sults in a significant reduction in fecal
iron concentrations, further underscoring
the crucial role of iron in infection.
Although intestinal iron absorption ap-
peared to be reduced as a consequence
of an inflammation-driven reduction in
ferroportin expression, this decrease in
intestinal iron content might be due to
iron trapping by lipocalin 2 in the intes-
tine, reduced food intake, or iron con-
sumption by bacteria. Then, the authors
studied the effects of administering the
probiotic bacterium Escherichia coli
Nissle 1917 on the course of S. Typhimu-
rium-induced colitis. They found that
inoculating E. coli Nissle 3 days after
the establishment of S. Typhimurium
infection resulted in intestinal E. coli
Nissle colonization and an impressive
reduction in S. Typhimurium colonization.
This effect was only found with wild-type
E.coli Nissle, and E. coli Nissle strains
with mutations in the iron uptake machin-
ery were unable to outcompete Salmo-
nella. Interestingly, this effect of E. coli
Nissle was critically dependent on the
presence of lipocalin 2, which scavenges
bacterial enterobactin, but not the side-
rophore salmochelin, produced by4 Cell Host & Microbe 14, July 17, 2013 ª201Salmonella (Andrews-Polymenis et al.,
2010; Chakraborty et al., 2012). This
finding suggests that E. coli Nissle can
successfully compete with Salmonella
for iron acquisition by non-enterobactin-
mediated pathways and, thus, reduce
the growth of this pathogenic bacterium
(Andrews-Polymenis et al., 2010). This
is consistent with the hypothesis that
E. coli Nissle harbors iron uptake
systems that are not targeted by lipoca-
lin 2. This enables probiotic bacterium
to colonize the same intestinal niche
as pathogenic bacteria such as
S. Typhimuirum because inflammation
leads to the increased expression of lipo-
calin 2, which normally causes a hostile,
iron-deprived environment that cannot
be colonized by commensal E. coli and
several other bacteria of the microbiome.
Deriu et al. (2013) also found that the
ingestion of E .coli Nissle exerted sus-
tained anti-inflammatory effects in mice
suffering from S. Typhimurium colitis.
This could be a consequence of the
replacement of pathogenic Salmonella
by E. coli Nissle and also due to a reduc-
tion in intestinal iron content via increased
ingestion of the metal by the probiotic
bacteria. Previous studies have shown
that a reduction of intestinal iron sulfate
content ameliorates the inflammatory
activity in the gut lumen and that modifi-
cation of iron homeostasis exerts anti-
inflammatory effects by reducing local
radical formation (Werner et al., 2011),
decreasing the production of the inflam-
matory cytokine TNF-a or increasing the
expression of the anti-inflammatory cyto-
kine IL-10 (Fritsche et al., 2012; Nairz
et al., 2010). Consistent with the findings
by Deriu et al. (2013), oral E. coli Nissle
administration was shown to exert anti-
inflammatory effects by modifying host
immune responses (Arribas et al., 2009),
which, again, may be traced back to
modification of intestinal and body iron
homeostasis and/or regulation of intesti-
nal immune responses by bacterial prod-
ucts or metabolites.3 Elsevier Inc.In summary, this study provides an
elegant explanation for the beneficial
effects of a specific probiotic bacterium
in inflammatory intestinal disorders and
adds an important facet toward under-
standing the role of iron in infection. Spe-
cifically, this evidence indicates that
various bacteria can directly compete for
iron sources, allowing bacteria that are
better equipped with high-affinity iron up-
take armatures to survive at the cost of
the other strain. This study will also most
likely initiate additional research aimed
at characterizing the advantageous iron
acquisition systems of E. coli Nissle and
potentially tailoring or generating probi-
otic bacteria to express enhanced iron
acquisition systems as treatments for
intestinal infections and inflammatory
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